eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

Aim and Scope

Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology. The articles in this journal are published open access (OA). Papers should be submitted in English to the Editorial Office by electronic editorial system at the following URL:
They will be published both in paper and on-line. Tables and figures should be submitted separately; linked files such as images or charts should also be provided. Authors are requested not to submit the manuscripts by post or e-mail.
The type of work, the authors and their affiliations, as well as title, abstract and key words should be entered in the appropriate places in the electronic submission panel. Please do not submit data of the authors (personal information and affiliations) in the file content of the work.

Publication charge
Please note that since 12th October 2023 there is an obligatory charge (= 800 Euro/3600 PLN) for each manuscript submitted and accepted for publication in Clinical and Experimental HepatologyTermedia Sp. z o.o. does not pay bank transfer costs. There are no additional charges for colour photos and other graphics.

Submitting authors or first authors are entitled to exemption from the fee for publication in CEH if they meet one of the following criteria:

a) are a member of the Polish Association for the Study of the Liver (PASL, PTHepat),

b) are members of the Editorial Board of Clinical and Experimental Hepatology,

c) reviewed articles for Clinical and Experimental Hepatology at least twice in the past year.

Authors should send us proper postal and e-mail addresses and all necessary data for the invoice including the editorial number of your publication. We shall send an invoice for payment after articles are accepted for publication. During a bank transfer please indicate your name in addition to the editorial number of the paper (e.g. John Smith, CEH No. CEH-00004-2023-01).
PayPal (EUR) is the preferred way of payment. However, if this is impossible, payments can be made directly to the following bank accounts:

Payment in EUR:
PL 21 1090 1359 0000 0001 0601 0708
Termedia sp. z o.o.
ul. Kleeberga 8
61-615 Poznań
- amount: 800 EUR
- title: Publication fee for ARTICLE-SIGNATURE

Payment in PLN:
PL 61 1090 1359 0000 0000 3505 2645
Termedia sp. z o.o.
ul. Kleeberga 8
61-615 Poznań
- amount: 3600 PLN
- title: Publication fee for ARTICLE-SIGNATURE

The first authors or submitting authors who are members of PTHepat (PASL), members of the Editorial Board (Clinical and Experimental Hepatology) or reviewed articles for Clinical and Experimental Hepatology at least twice in the past year should indicate this information in the editorial panel when submitting their manuscript by the Editorial System. After verification by the editors, this will be the basis for exemption from the fee for publishing the article.

The fee applies only to the cost of preparing / developing the article for publication in the journal. The fee has no effect on the acceptance of the article for publication. All articles submit by editorial system are reviewed by independent experts outside the editorial office and based on their opinions are qualified or not for publication.
Please be informed that if the author decides not to publish the work, which was already accepted and paid, the fee paid will not be returned for reasons beyond the Publisher’s control.

Preparation of manuscripts
Please follow the instructions relevant to type of manuscript being submitted.
Original papers should be structured in the following order: Introduction, Material and methods, Results, Discussion, Conclusions, Acknowledgments and Disclosure, References. A Statistical analysis section must be included where relevant in Material and methods section. Papers should contain up to 5 key words.
The title must not exceed 150 characters. The total length of the manuscript, including figures and tables, should not exceed 4000 words and 30 references.
Abstracts of original papers should be structured (incorporating the following sections: Aim of the study, Material and methods, Results and Conclusions) and must not exceed 250 words in length. As this may be the only part of the article read by some readers it must include sufficient details for an adequate summary of the whole manuscript.
Review articles should follow the format for a regular article and should contain unstructured abstract containing no more than 150 words and up to 5 key words. Authors are encouraged to use section headings for ease of reading. The total length of the manuscript including figures and tables should not exceed 4000 words and 50 references.
Editorials are written on invitation and should have an unstructured abstract of up to 150 words. The total length of the editorial should not exceed 2000 words and 20 references.

Tables require a brief but descriptive heading. The major divisions of the table should be indicated by horizontal rules. Explanatory matter should be included in footnotes, indicated in the body of the table in order of their appearance. Tables should be numbered consecutively throughout the text. Tables must not duplicate material in the text or in illustration.

Figures should be of the resolution of at least 300 dpi and should be sumbited in .tif, .jpg, .ppt or .xls format. All figures, whether photographs, graphs or diagrams, should be numbered consecutively throughout the text. Only good drawings and original photographs can be accepted. If a figure (image) has been published previously, the original source must be acknowledged and written permission to reproduce the material from the copyright holder must be submitted.

All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text. References should contain names and initials of the first three authors, then „et al.”; article title, Index Medicus abbreviation for the journal title, year of issue, volume and inclusive pages. Chapters in books or monographs should be cited as follows: names and initials of authors, chapter title, book title, name and initial of the book editor, volume, name of the publisher, place of publishing, year, pages.
– article:
Flisiak R, Halota W, Horban A, et al. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol 2011; 23: 1213-1217.
– book chapters:
Dienstag JL. Przewlekłe zapalenia wątroby. In: Harrison – choroby zakaźne. Kasper DL, Fauci AS (eds.). Vol. 2. Wydawnictwo Czelej, Lublin 2012; 1235-1264.
– conference abstracts:
Marcellin P, Buti M, Gane E, et al. Six years of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection is safe and well tolerated wna associated with sustained virological, biochemical and serological responses with no detectable resistance. VI Zjazd PTHepat. Exp & Clin Hepatology 2013; 9: A15.
– internet publication:
United Nations. World population prospects: 2010 revision, available from: http://esa.un.org/unpd/wpp/index.htm

Conflict of interest, righst and permissions
The author submitting the manuscript for publication in the Clinical and Experimental Hepatology journal is fully liable for it and represents that:

• the work has not been published elsewhere,

• the work is not currently under consideration for publication in other journals,

• that no conflicts of interest exist in relation to the submitted work (or declare – Authors are expected to describe sources of the research founding, a role of potential sponsor in planning, executing and analysis of the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflict of interest in relation to the submitted article should also be disclosed),

• the author holds copyrights to the material submitted (text, photographs, figures, illustrations and any other elements representing a separate work within the meaning of Copyrights Law) making up the article and hence he may submit it on terms set out in the instructions for Authors, and in particular that the publication of the material will not infringe third party rights.

If any claims related to or referring to the material submitted are made by third parties against the Editor and/or Termedia publishers, the submitting Author will indemnify the Editor-in-Chief, editorial staff and Termedia publishers and hold them harmless in respect of the resultant costs. If the work is submitted as a joint work (by several authors), the submitting Author represents that he holds an adequate (valid and irrevocable) power of attorney to represent all other co-authors of material submitted and any representations concerning copyrights of material submitted apply also to other co-authors.

Submission of the work for publication in the Clinical and Experimental Hepatology journal is tantamount to the consent to the transfer of copyrights to the manuscript to the journal owner, free of charge, if the article is accepted for publication.

The copyrights transfer includes the use of the work by way of the fixing, reproducing and publishing it in print and electronic form (CD-ROM, electronic version available on the publishers’ website).

Patients’ Rights and Informed Consent
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2000 (concerning the ethical principles for the medical community and forbidding releasing the name of the patient, initials or the hospital evidence number) and with the ethical standards of the responsible committee on human experimentation (institutional and national). Information regarding the ethical committee approval for conducting the research and the informed consents of patients for participating in the studies should be included in the methods section of those articles, in which the diagnostic intervention or the treatment result from non-routine procedures.
The authors presenting case studies are obligated not to disclose patients’ personal data. Regarding photographs, in case of any doubt the picture inadequately protects the patient’s anonymity his consent is required for publication. Articles describing animal studies should contain information of being in accordance with local regulations (institutional and national).

The scope of work of the authors
The journal applies procedures ensuring the originality of manuscripts in accordance with the criteria of the ICMJE (International Committee of Medical Journal Editors) and WAME (World Association of Medical Editors). Therefore it is also necessary to provide information on the scope of input of each author to the publication, among others who is the author of the concept of the study, assumptions, methods, study protocol, and the like, as well as on the affiliation of each of the authors. The Editorial Office observes the highest standards of scientific publication and the cooperation with authors is based on the transparency of information on the actual input of persons/institutions in the development of the publication. The Clinical and Experimental Hepatology will not tolerate plagiarism in any form. All cases of ghostwriting and guest authorship will be liable for customary penalty as an indication of scientific negligence.

Review process
Manuscripts submitted to the Editorial Office are assessed by reviewers.The rules of review are in conformity with the guidelines of the Ministry of Science and Higher Education (www.nauka.gov.pl).
The Clinical and Experimental Hepatology has always used a double-blinded peer review process. The Editorial Office verifies that the submitted manuscript complies with the journal’s formal requirements and its profile. If the manuscript evidently does not match the profile of the journal, or if it fails to comply with the basic formal requirements, it is rejected at this stage. Manuscripts that receive positive in-house reviews are followed by peer review by at least two reviewers.
The Editorial Office chooses the reviewers based on the subject of the submitted manuscript. The competences of a reviewer are confirmed by the academic achievements. The reviewer is independent of the author of the reviewed manuscript and the Editorial Office of the journal.
An invited reviewer has 7 days to accept or decline the invitation to review. In the review process following qualities are evaluated: the novelty of the manuscript, importance of obtained results, methods, statistical analysis and data quality, the presentation of results, the quality of discussion and appropriate selection of the literature. Evaluation takes place in the points system, using a special form of reviews, which is available only to the Editors. Besides, the review should include: conclusion on the overall assessment of the manuscript (accept without change, accept after minimal changes, rate manuscript once again after major changes or reject), and final remarks.
The process of evaluation will not take more than 21 days. The recommendations of the reviewers are presented to the author in writing. The review procedure respects the principle of confidentiality.
The Editorial Office reserves the right to reduce manuscripts and to make language corrections without consulting the author. Other changes are consulted with the authors.

Authors will receive a proof from an Assistant Editor. That proof should be corrected and returned within 48 hours, preferably by e-mail or fax. If the Publisher receives no response from the authors after 7 days, it will be assumed that there are no errors to correct and the article will be published.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.